Type 2 Diabetes Management


Internet Enduring Material Sponsored by the Stanford University School of Medicine. Presented by the Department of Medicine, division of Endocrinology, Gerontology and Metabolism at the Stanford University School of Medicine.

Course Description

This CME activity provides a practical approach to lifestyle and medication management for type 2 diabetes mellitus. The course will take the learner through a case-based learning activity focusing on new medications and medication algorithms. Note: Insulin therapy is not addressed in this course. The course will also address culturally sensitive food-based counseling to facilitate lifestyle modifications.

Intended Audience

This course is designed for physicians and allied health professionals in cardiology, family practice, primary care, internal medicine, neurology and oncology.

Dates, Duration and Fee

  • Release Date: December 20, 2018
  • Expiration Date: December 20, 2021
  • Estimated Time to Complete:  1.25 Hours
  • CME Credits Offered: 1.25
  • Registration Fee: FREE

To Obtain CME Credits

  • Review the information below and complete the entire activity.
  • Complete the CME Post-test, CME Assessment Survey, and CME Activity Completion Statement at the end of the activity.
  • You must receive a score of 75% or higher on the post-test in order to receive a certificate. You will have two attempts to answer each multiple-choice question (or one attempt for questions with only two options) to pass the post-test.
  • Once you attest to completing the entire online activity and have scored 75% or higher on the post-test, your certificate will be generated automatically and will be available on your Dashboard page.
  • Physicians will be awarded AMA PRA Category 1 Credits™. All other participants will receive a Certificate of Participation.

Learning Objectives

At the conclusion of this activity, participants should be able to:

  • Recognize the new/most recent treatment options for type 2 diabetes.
  • Evaluate patients for appropriate treatments and comorbidities.
  • Evaluate patients for medication/ treatment adherence.
  • Formulate progression of treatment plans for patients who haven't improved on current regimens.
  • Use culturally sensitive communication tactics when discussing importance and safety of medication and treatment adherence with patients.



Test Your Knowledge

Prevalence in US and Diagnostic Criteria

Algorithm for Antihyperglycemic Therapy

Interactive PDF Algorithm

Lifestyle Management

Case 1: Maria

Case 2: Marcus


Course Wrap-Up

Resources and References



The following planners, authors and speakers have indicated that that they have no relationships with industry to disclose relative to the content of this activity:

Marina Basina, MD
Clinical Associate Professor of Medicine - Endocrinology, Gerontology and Metabolism
Stanford University School of Medicine
Course Director

Leticia Wilke, CNS
Clinical Nurse Specialist
Stanford Health Care

Leah Groppo, MS, RD, CDE
Clinical Dietitian
Stanford Health Care

Kathleen Judge, CNS
Clinical Nurse Specialist
Stanford Health Care
Author, Speaker

Technical Design and Development

Hardware/Software Requirements

  • Computer with Internet connection
  • Current version of Chrome, Firefox or Safari browser. You must have javascript enabled.

Accreditation and Designation of Credits

The Stanford University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The Stanford University School of Medicine designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

The American Nurses Credentialing Center (ANCC) accepts AMA PRA Category 1 Credit TM from organizations accredited by the ACCME. Please check with your state’s credentialing board for their requirements.

Commercial Support Acknowledgement

Stanford University School of Medicine has received and has used undesignated program funding from Pfizer, Inc. to facilitate the development of innovative CME activities designed to enhance physician competence and performance and to implement advanced technology. A portion of this funding supports this activity.


Cultural and Linguistic Competency

California Assembly Bill 1195 requires continuing medical education activities with patient care components to include curriculum in the subjects of cultural and linguistic competency. It is the intent of the bill, which went into effect July 1, 2006, to encourage physicians and surgeons, CME providers in the State of California and the Accreditation Council for Continuing Medical Education to meet the cultural and linguistic concerns of a diverse patient population through appropriate professional development. The planners and speakers of this CME activity have been encouraged to address cultural issues relevant to their topic area. The Stanford University School of Medicine Multicultural Health Portal also contains many useful cultural and linguistic competency tools including culture guides, language access information and pertinent state and federal laws.

CME Privacy Policy


If you are having problems, contact the CME Online support team at CMEonline@stanford.edu and we will follow-up with you to resolve your issue.


Marso SP, Daniels GH, Brown-Frandsen K, et al.; LEADER Steering Committee; LEADER Trial Investigators. Liraglutide and cardiovascular out-comes in type 2 diabetes. N Engl J Med 2016;375:311-322

Frederich R, Lewis BS, McGuire DK, Davidson J, Steg PG, Bhatt DL; SAVOR-TIMI 53 Steering Committee and Investigators. Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 random-ized trial. Circulation. 2014;130:1579–1588. doi: 10.1161/CIRCULATIONAHA.114.010389.

EXAMINE trial:
Zannad F, Cannon CP, Cushman WC, Bakris GL, Menon V, Perez AT, Fleck PR, Mehta CR, Kupfer S, Wilson C, Lam H, White WB; EXAMINE Investigators. Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial. Lancet. 2015;385:2067–2076. doi: 10.1016/S0140-6736(14)62225-X.

Williams-Herman D, Johnson J, Teng R, et al. Efficacy and safety of initial combination therapy with sitagliptin and metformin in patients with type 2 diabetes: a 54-week study. Curr Med Res Opin. 2009 Mar;25(3):569–83. 2009. [PubMed] 2015.

For a complete list, please view the References/Bibliography page in the Course.

©2018 Stanford University School of Medicine

Course Details

  • Ongoing registration for this self-paced course is available until: December 20, 2021 
  • Estimated Time to Complete: 1.25 hours
  • CME Credits Offered: 1.25
  • Registration Fee: FREE

Contact Information

If you are having problems, contact the CME Online support team at CMEonline@stanford.edu and we will follow-up with you to resolve your issue.

Join our mailing list

New activities are added regularly. Join our mailing list to receive notifications about activities of interest to you.